Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR0302 in Non-segmental Vitiligo
NCT07251595Phase 2Recruiting
- Sponsor
- Hengrui
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivarmacitinib in Vitiligo, sponsored by Hengrui. Started Dec 2025; status: recruiting.
02
Drugs
ivarmacitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07251595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07251595.